ArticleEpilepsia2026
Influence of histopathologic type of hippocampal sclerosis on neuropsychological profile.
Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveHippocampal sclerosis (HS) is the most common histopathological abnormality in adults with drug-resistant mesial temporal lobe epilepsy (MTLE) who are candidates for surgery. In 2013, the International League Against Epilepsy (ILAE) Task Force subdivided HS into three types: HS-ILAE type 1 (severe neuronal loss and gliosis predominantly in CA1 and CA4), HS-ILAE type 2 (CA1-predominant), and HS-ILAE type 3 (CA4-predominant). The aim of this study was to assess the association between HS-ILAE types and cognitive profiles of MTLE-HS patients.
methodsA total of 302 patients were retrospectively included, comprised of 253 MTLE-HS patients with a postoperative ILAE classification of HS as follows: 194 HS-ILAE type 1, 57 HS-ILAE type 2, and two HS-ILAE type 3; and 49 MTLE patients without HS. Demographic variables, clinical characteristics, postoperative outcome, and cognitive performance were compared between patients with HS-ILAE type 1, with HS-ILAE type 2, and without HS, who served as internal controls. Height cognitive domains were examined: general cognition, verbal and nonverbal episodic memory, language, executive functions, short-term and working memory, perceptual-motor speed, and visuoconstructive abilities.
resultsThe pattern of hippocampal neuronal loss was not associated with age at epilepsy onset, the presence of specific initial precipitating events, other clinical characteristics, or postoperative outcome. Patients with HS-ILAE type 1 demonstrated significantly poorer performance in visuoconstructive and language tasks compared with those with HS-ILAE type 2 or patients without HS. No significant differences were observed between groups in verbal and nonverbal episodic memory, short-term memory, executive functions, or perceptual-motor speed. SIGNIFICANCE: HS-ILAE subtype has a modest yet differential impact on patient performance, with HS-ILAE type 1 patients demonstrating overall poorer outcomes across two cognitive domains: language and visuoconstructive function. These findings suggest that cognitive impairment in MTLE-HS likely reflects a complex interplay among multiple pathological processes, including, in part, neuronal loss within specific hippocampal subfields. More targeted neuropsychological assessments focusing on the functional integrity of distinct hippocampal subregions are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.